The premarket trading on Friday has seen the three stocks in this analysis looking very much like a choppy session is about ...

XRP price may have finally found its floor. On-chain data and momentum signals hint at recovery—but only if key levels hold.

Following in the footsteps of BTC, BNBUSD shed most of its gains. Having reached $1022intraday, it is now trading at about ...

The Israel-based company, which developed Elfabrio alongside Chiesi Global Rare Diseases, part of Italy-based Chiesi Group, had been seeking approval for a new, less frequent dosing regimen for ...

According to experts, the Nifty 50 is expected to see a falling resistance trendline breakout (around 25,380), followed by 25 ...

Protalix ( ($PLX) ) has issued an announcement. On October 17, 2025, Protalix BioTherapeutics and its partner Chiesi Global Rare Diseases ...

USDCHFpared most of its gains on board-based US dollar selling. Currently trading at 0.78989, it reached anintradaylowof ...

Ether is down 7% in the last 24 hours and could extend its decline towards the $3,500 low as selling pressure increases.

DOGE’s price weak rebound faces pressure as long-term holders sell and price risks retesting its 13-month low.

Sugandha Sachdeva recommends four shares to buy for medium term — Cochin Shipyard, Technocraft Industries, HG Infra ...

As Bitcoin hovers around $108K, prediction markets flip bearish while short-term indicators confirm what bulls don't want to ...

On October 17, 2025, Insmed announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of BRINSUPRI for non-cystic ...